218 related articles for article (PubMed ID: 21558290)
21. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome.
Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X
Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501
[TBL] [Abstract][Full Text] [Related]
22. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of IgG anti-{alpha}-fodrin antibodies in Sjogren's syndrome.
Ruiz-Tíscar JL; López-Longo FJ; Sánchez-Ramón S; Santamaría B; Urrea R; Carreño L; Estecha A; Vigil D; Fernández-Cruz E; Rodríguez-Mahou M
Ann N Y Acad Sci; 2005 Jun; 1050():210-6. PubMed ID: 16014536
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory features of Sjögren's syndrome in young women with previous postpartum thyroiditis.
Gudbjörnsson B; Karlsson-Parra A; Karlsson E; Hällgren R; Kämpe O
J Rheumatol; 1994 Feb; 21(2):215-9. PubMed ID: 8182627
[TBL] [Abstract][Full Text] [Related]
25. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
[TBL] [Abstract][Full Text] [Related]
26. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
27. Phenotypic features and predictors of the clinical severity of keratoconjunctivitis sicca and salivary gland dysfunction in patients with Sjögren's syndrome: a longitudinal analysis of the Korean Initiative of primary Sjögren's Syndrome (KISS) cohort.
Koh JH; Lee J; Chung SH; Kwok SK; Park SH
Scand J Rheumatol; 2019 May; 48(3):198-206. PubMed ID: 30475093
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of IgA Anti-α-fodrin Antibodies in Combination with Rheumatoid Factor and/or Antinuclear Antibodies as Substitute Immunological Criterion in Sjögren Syndrome with Negative Anti-SSA/SSB Antibodies.
Hernández-Molina G; Nuñez-Alvarez C; Avila-Casado C; Llorente L; Hernández-Hernández C; Calderillo ML; Marroquín V; Recillas-Gispert C; Romero-Díaz J; Sánchez-Guerrero J
J Rheumatol; 2016 Oct; 43(10):1852-1857. PubMed ID: 27481899
[TBL] [Abstract][Full Text] [Related]
29. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
[TBL] [Abstract][Full Text] [Related]
30. Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome.
Maran R; Dueymes M; Pennec YL; Casburn-Budd R; Shoenfeld Y; Youinou P
J Autoimmun; 1993 Jun; 6(3):379-87. PubMed ID: 8397718
[TBL] [Abstract][Full Text] [Related]
31. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
32. Serologic studies in patients with keratoconjunctivitis sicca.
Forstot SL; Forstot JZ; Peebles CL; Tan EM
Arch Ophthalmol; 1981 May; 99(5):888-90. PubMed ID: 6972210
[TBL] [Abstract][Full Text] [Related]
33. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
34. Sjogren's syndrome and keratoconjunctivitis sicca.
Farris RL; Stuchell RN; Nisengard R
Cornea; 1991 May; 10(3):207-9. PubMed ID: 2055025
[TBL] [Abstract][Full Text] [Related]
35. Centromere protein C is a target of autoantibodies in Sjögren's syndrome and is uniformly associated with antibodies to Ro and La.
Pillemer SR; Casciola-Rosen L; Baum BJ; Rosen A; Gelber AC
J Rheumatol; 2004 Jun; 31(6):1121-5. PubMed ID: 15170924
[TBL] [Abstract][Full Text] [Related]
36. Similarities and differences between primary and secondary Sjögren's syndrome.
Hernández-Molina G; Avila-Casado C; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín V; Soto-Abraham V; Recillas-Gispert C; Sánchez-Guerrero J
J Rheumatol; 2010 Apr; 37(4):800-8. PubMed ID: 20194453
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression.
Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J
J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127
[TBL] [Abstract][Full Text] [Related]
38. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome.
Katano K; Kawano M; Koni I; Sugai S; Muro Y
J Rheumatol; 2001 Oct; 28(10):2238-44. PubMed ID: 11669163
[TBL] [Abstract][Full Text] [Related]
39. [Sjögren syndrome in ORL. Diagnostic considerations].
Leache Pueyo JJ; Sevil Navarro J; Del Agua C
An Otorrinolaringol Ibero Am; 2001; 28(1):39-49. PubMed ID: 11265517
[TBL] [Abstract][Full Text] [Related]
40. [Anti-SS-A/Ro, anti-SS-B/La antibody].
Okano T; Satoh M; Akizuki M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():541-4. PubMed ID: 20942124
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]